Literature DB >> 26195942

Cardiac Toxicity after Radiotherapy for Breast Cancer: Myths and Facts.

Mirko Nitsche1, René Pahl2, Karen Huber2, Kirsten Eilf2, Juergen Dunst2.   

Abstract

Radiotherapy is an important component in the multidisciplinary treatment of breast cancer. In recent years, the cardiac risks of radiation have been discussed several times. This problem has long been known and resolved from the radiotherapeutic point of view. The current data is briefly described here.

Entities:  

Keywords:  Breast cancer Cardiotoxicity Radiotherapy

Year:  2015        PMID： 26195942      PMCID： PMC4464015          DOI： 10.1159/000376560

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


  34 in total

1.  Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease.

Authors:  Wolfram Machann; Meinrad Beer; Margret Breunig; Stefan Störk; Christiane Angermann; Ines Seufert; Franz Schwab; Oliver Kölbl; Michael Flentje; Dirk Vordermark
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-10       Impact factor: 7.038

2.  Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions.

Authors:  Thomas Mulliez; Liv Veldeman; Annick van Greveling; Bruno Speleers; Simin Sadeghi; Dieter Berwouts; Frederik Decoster; Tom Vercauteren; Werner De Gersem; Rudy Van den Broecke; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

Review 3.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

4.  Prone vs supine positioning for breast cancer radiotherapy.

Authors:  Silvia C Formenti; J Keith DeWyngaert; Gabor Jozsef; Judith D Goldberg
Journal:  JAMA       Date:  2012-09-05       Impact factor: 56.272

5.  Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk.

Authors:  Mari H B Hjelstuen; Ingvil Mjaaland; Johan Vikström; Kjell Ivar Dybvik
Journal:  Acta Oncol       Date:  2011-12-16       Impact factor: 4.089

Review 6.  Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.

Authors:  J Cuzick; H Stewart; R Peto; M Baum; B Fisher; H Host; J P Lythgoe; G Ribeiro; H Scheurlen; A Wallgren
Journal:  Cancer Treat Rep       Date:  1987-01

7.  Acute cardiotoxicity with concurrent trastuzumab and radiotherapy including internal mammary chain nodes: a retrospective single-institution study.

Authors:  Richard Shaffer; Scott Tyldesley; Martin Rolles; Stephen Chia; Islam Mohamed
Journal:  Radiother Oncol       Date:  2008-10-29       Impact factor: 6.280

8.  Radiation-induced heart disease: morphology, changes in catecholamine synthesis and content, beta-adrenoceptor density, and hemodynamic function in an experimental model.

Authors:  S Schultz-Hector; M Böhm; A Blöchel; P Dominiak; E Erdmann; W Müller-Schauenburg; A Weber
Journal:  Radiat Res       Date:  1992-03       Impact factor: 2.841

9.  Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients.

Authors:  Henrik D Nissen; Ane L Appelt
Journal:  Radiother Oncol       Date:  2012-11-28       Impact factor: 6.280

10.  Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer.

Authors:  K E Henson; P McGale; C Taylor; S C Darby
Journal:  Br J Cancer       Date:  2012-12-20       Impact factor: 7.640
View more
  4 in total

Review 1.  Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast Cancer.

Authors:  Mirko Nitsche; Juergen Dunst; Ulrich M Carl; Robert M Hermann
Journal:  Breast Care (Basel)       Date:  2015-07-10       Impact factor: 2.860

2.  Feasibility of using calibrated cone-beam computed tomography scans to validate the heart dose in left breast post-mastectomy radiotherapy.

Authors:  Bin Tang; Jiabao Ma; Jinghui Xu; Jie Li; Shengwei Kang; Pei Wang; Fan Wu; Lucia Clara Orlandini
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 3.  Recent advances in radiotherapy of breast cancer.

Authors:  Jan Haussmann; Stefanie Corradini; Carolin Nestle-Kraemling; Edwin Bölke; Freddy Joel Djiepmo Njanang; Bálint Tamaskovics; Klaus Orth; Eugen Ruckhaeberle; Tanja Fehm; Svjetlana Mohrmann; Ioannis Simiantonakis; Wilfried Budach; Christiane Matuschek
Journal:  Radiat Oncol       Date:  2020-03-30       Impact factor: 3.481

4.  Advantages of a technique using two 50 degree arcs in simultaneous integrated boost radiotherapy for left-sidebreast cancer.

Authors:  Dan Xi; Yun Ding; Rui Hu; Wendong Gu; Jinming Mu; Qilin Li
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.